Definitive Contract HHSN261201200070C
Award Date 9/28/12
Potential Completion Date 6/27/13
Potential Value $200K
Federal Agency
Ultimate Awardee
Not listed NAICS Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
Total Small Business
Extent Competed
Full and Open Competition after exclusion of sources
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Hamilton Township, NJ 08610, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
45
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- <p>This is a $198,751 Small Business Innovation Research (SBIR) Phase I contract awarded by the National Cancer Institute (NCI), a civilian agency, to Genomic Systems, LLC. The contract is for research and development in the TAS::75 0849::TAS area and has a period of performance ending on September 30, 2011. This SBIR Phase I contract was awarded on a Firm Fixed Price basis.</p>
- This federal contract award, HHSN261201000135C, was issued by the National Cancer Institute, a civilian agency, to the small business prime contractor 20 / 20 Genesystems, Inc. (doing business as 20 / 20 Genomics). The award has a ceiling value of $182,576.00 and is a definitive, firm-fixed-price contract with a completion date of November 29, 2011. The contract is set aside for small businesses. The work to be performed under this contract is described in the solicitation as "TAS::75...
- This is a $1,698,988.00 Firm Fixed Price contract awarded by the National Cancer Institute (NCI), which is part of the U.S. Department of Health and Human Services (HHS), to Insight Genetics, Inc., a small business. The contract is for "OTHER FUNCTIONS - R & D BIOMEDICAL (BASIC RESEARCH)" and has a total small business set-aside designation. The contract was awarded on September 20, 2012 and has an ultimate completion date of August 16, 2015. This contract award is not associated...
- This firm fixed-price contract was awarded by the National Cancer Institute (NCI), part of the National Institutes of Health (NIH), to Genedx, LLC, a provider of genetic testing and diagnostic services. The $5,250 contract tasks Genedx with providing a range of genetic testing services, including mutation analysis, exome and genome sequencing, gene panel testing, and mitochondrial testing, in support of NIH's clinical research missions. This contract is not set aside for any socioeconomic...
- This is a $17,914,968.82 cost-plus-fixed-fee delivery order contract awarded by the National Cancer Institute (NCI), a civilian agency within the U.S. Department of Health and Human Services, to General Dynamics Information Technology, Inc. (GDIT), a major IT services provider. The contract supports the Cancer Genome Atlas (TCGA) program by providing tissue samples and data from various types of cancer. It was funded through the American Recovery and Reinvestment Act (ARRA) and has an ultimate...
- The Department of Health and Human Services National Institutes of Health National Cancer Institute awarded a $447,735.56 delivery order contract to Government Scientific Source Inc., doing business as G S S, to purchase Brand-Name 10X Genomics kits and reagents in support of the NIH/NCI/CCR/Surgery Branch/Next-Generation Sequencing Genomic Core Facility. The contract was awarded against G S S's Multiple Award Schedule contract vehicle and has a period of performance from September 15, 2023...
- The Department of Health and Human Services National Institutes of Health National Human Genome Research Institute awarded a $122,908.83 firm fixed price delivery order contract to Government Scientific Source Inc. (GSS) for 10X GENOMICS INC CHROMIUM NEXT GEM SINGLE CELL MULTIOME ATAC GENE E. This contract was not set aside for any small business designation. GSS is a leading distributor of laboratory products and equipment, serving federal, state, and local governments. They have provided a...
- The U.S. Department of Health and Human Services (HHS) - National Institutes of Health (NIH) awarded a $5,675.00 firm fixed-price purchase order contract to Medgenome Inc., a small business, for genomic sequencing and data services. The contract has an ultimate completion date of June 30, 2025 and was awarded on August 29, 2024. The contract is not set-aside. Medgenome Inc. provides a range of scientific services, primarily in the field of genomics and lab testing, including genomic...
- Government Scientific Source Inc., doing business as G S S, has been awarded a $94,286.90 delivery order against its Multiple Award Schedule contract by the National Cancer Institute within the National Institutes of Health of the Department of Health and Human Services. Under this firm fixed price order, G S S will provide 10X Genomics' Chromium X instrument with accessories and a 12-month warranty to the Herndon, Virginia area in support of the National Cancer Institute's biomedical research...
- This is a Small Business Innovation Research (SBIR) Phase I contract awarded by the National Cancer Institute (NCI), a component of the National Institutes of Health (NIH), to Personal Genome Diagnostics Inc., a for-profit company that provides molecular tissue testing services to federal agencies. The contract has a ceiling value of $222,994.00 and is a firm-fixed-price definitive contract for the development of a non-invasive approach to assess mutation load in tumors for treatment with...